Search Results 1031-1040 of 18166 for monoclonal antibody

  1. High blood protein Causes - Mayo Clinic

    Monoclonal gammopathy of undetermined significance (MGUS) ... Proteins take a variety of forms, such as albumin, antibodies and enzymes, and have many different ...

  2. A Study Comparing JNJ-79635322 And An Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody In Participants With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    A Study Comparing JNJ-79635322 And An Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody In Participants With Relapsed Or Refractory Multiple Myeloma.

  3. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    ... monoclonal antibodies, radioimmunoconjugates, or antibody-drug ... monoclonal antibody therapy (or recombinant antibody-related fusion proteins) * ...

  4. A Study Of SPX-303, A Bispecific Antibody Targeting LILRB2 And PD-L1 In Patients With Solid Tumors - Mayo Clinic

    Part 1 of this study is an open-label, dose-escalation, and safety expansion study of an anti-LILRB2 / anti-PD-L1 bispecific antibody SPX- 303 in patients with ...

  5. Publications - Zelalem Temesgen, M.D. - Mayo Clinic

    Anti-gm-csf monoclonal antibody treatment of chronic myelomonocytic leukemia treatment of Covid-19. Drugs of the Future. 2022 Dec; 47 (12):887-92; Drummond ...

  6. Small lymphocytic lymphoma - Symptoms and causes - Mayo Clinic

    Monoclonal B-cell lymphocytosis (MBL) causes an ... Sometimes infections happen because your blood doesn't have enough germ-fighting antibodies, called ...

  7. A Study Of Tazemetostat In Treating Patients With Recurrent Ovarian, Primary Peritoneal, Or Endometrial Cancer - Mayo Clinic

    Monoclonal antibody(ies). At least 28 days since last dose of monoclonal antibody prior to registration. Immunotherapy. At least 28 days since last dose of ...

  8. Novel Antineuronal Antibodies In Gastrointestinal Motility Disorders - Mayo Clinic

    The purpose of this study is to identify novel anti neuronal antibodies that contribute to autoimmune gastrointestinal motility disorders by analyzing the serum ...

  9. Model Clarifies Immunotherapy for Multiple Myeloma - Mayo Clinic News Network

    The researchers used an immunotherapy called "bispecific T cell engaging antibodies" combined with chemotherapy or other immunomodulators. Bispecific-T-cell- ...

  10. Study Of DF9001 In Patients With Advanced Solid Tumors - Mayo Clinic

    ... antibody, administered ... - History of or ongoing pulmonary fibrosis or interstitial lung disease. 10. Known severe hypersensitivity reactions to monoclonal ...